Secondary Logo

May-June 2004 - Volume 11 - Issue 3
pp: 239-367


Beneficial effect of soy isoflavones on bone mineral content was modified by years since menopause, body weight, and calcium intake: a double-blind, randomized, controlled trial

Chen, Yu-ming; Ho, Suzanne C.; Lam, Silvia S. H.; More

Menopause. 11(3):246-254, May-June 2004.

Chronic treatment with progesterone but not medroxyprogesterone acetate restores the endothelial control of vascular tone in the mesenteric artery of ovariectomized rats

Chataigneau, Thierry; Zerr, Murielle; Chataigneau, Marta; More

Menopause. 11(3):255-263, May-June 2004.

Validity of self-report for fractures among a multiethnic cohort of postmenopausal women: results from the Women's Health Initiative observational study and clinical trials

Chen, Zhao; Kooperberg, Charles; Pettinger, Mary B.; More

Menopause. 11(3):264-274, May-June 2004.

Effect of raloxifene on quality of life: a prospective study using the Utian Quality of Life (UQOL) Scale

Utian, Wulf H.; Janata, Jeffrey W.; Barbier, Suzanne; More

Menopause. 11(3):275-280, May-June 2004.

Influence of marketed herbal menopause preparations on MCF-7 cell proliferation

Bodinet, Cornelia; Freudenstein, Johannes

Menopause. 11(3):281-289, May-June 2004.

The effect of soy protein isolate on bone metabolism

Gallagher, J. Christopher; Satpathy, Ruby; Rafferty, Karen; More

Menopause. 11(3):290-298, May-June 2004.

The effect of hormone therapy and raloxifene on serum matrix metalloproteinase-2 and -9 in postmenopausal women

Christodoulakos, George E.; Panoulis, Constantinos P. C.; Lambrinoudaki, Irene V.; More

Menopause. 11(3):299-305, May-June 2004.

Body mass index does not influence response to treatment, nor does body weight change with lower doses of conjugated estrogens and medroxyprogesterone acetate in early postmenopausal women

Utian, Wulf H.; Gass, Margery L. S.; Pickar, James H.

Menopause. 11(3):306-314, May-June 2004.

Association between hormonal changes at menopause and the risk of a coronary event: a longitudinal study

Guthrie, Janet R.; Taffe, John R.; Lehert, Philippe; More

Menopause. 11(3):315-322, May-June 2004.

Association of cardiovascular risk factors with intima-media thickness of the carotid arteries in early postmenopausal women

Trémollieres, Florence A.; Bauvin, Eric; Cigagna, Florence; More

Menopause. 11(3):323-330, May-June 2004.

Substitution of transdermal estradiol during oral estrogen-progestin therapy in postmenopausal women: effects on hypertriglyceridemia

Sanada, Mitsuhiro; Tsuda, Mikio; Kodama, Ichiro; More

Menopause. 11(3):331-336, May-June 2004.

Trimegestone in a low-dose, continuous-combined hormone therapy regimen prevents bone loss in osteopenic postmenopausal women

Warming, Lise; Ravn, Pernille; Spielman, Danièle; More

Menopause. 11(3):337-342, May-June 2004.

A cost-effectiveness evaluation of two continuous-combined hormone therapies for the management of moderate-to-severe vasomotor symptoms

Botteman, Marc F.; Shah, Nisha P.; Lian, Jean; More

Menopause. 11(3):343-355, May-June 2004.

Bioidentical hormone therapy: a review

Boothby, Lisa A.; Doering, Paul L.; Kipersztok, Simon

Menopause. 11(3):356-367, May-June 2004.